Alembic Global Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC GLOBAL, and what generic and branded alternatives to ALEMBIC GLOBAL drugs are available?
ALEMBIC GLOBAL has one approved drug.
Summary for Alembic Global
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Alembic Global
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-003 | Feb 11, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-002 | Feb 11, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-004 | Feb 11, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-001 | Feb 11, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
